首页 > 最新文献

Journal of Pharmaceutical Policy and Practice最新文献

英文 中文
Real-world effectiveness of aromatase inhibitors and fulvestrant in HR+/HER2- advanced breast cancer: a snapshot of the last two years before conventional use of CDK 4/6 inhibitors in a Portuguese institution. 芳香化酶抑制剂和氟维司群在HR+/HER2-晚期乳腺癌中的实际疗效:葡萄牙一家机构在常规使用CDK 4/6抑制剂前两年的快照。
IF 4.2 Q1 HEALTH POLICY & SERVICES Pub Date : 2024-01-17 eCollection Date: 2024-01-01 DOI: 10.1080/20523211.2023.2296551
Maria Inês Teodoro, Alexandra Mayer, Ana da Costa Miranda, Hugo Nunes, Filipa Alves da Costa, António Lourenço

Background: Monotherapy with aromatase inhibitors and fulvestrant were the standard-of-care for hormone receptor-positive (HR+)/human epidermal growth factor receptor-type2 negative (HER2-) advanced breast cancer, before integration of cyclin-dependent kinase 4/6 inhibitors. Effectiveness data is essential for regulatory action, but little is known about real-world use of aromatase inhibitors and fulvestrant.

Methods: A retrospective cohort study was conducted resorting to data from a cancer registry to identify adult women with HR+/HER- advanced breast cancer exposed to aromatase inhibitors or fulvestrant (31 May 2017-31 March 2019) at the main oncology hospital in Portugal. Cases were updated with follow-up until death or cut-off (31 March 2021) and pseudoanonymized data extracted. Primary outcome was overall survival (OS) and secondary time to treatment failure (TTF), estimated using survival analysis and compared with published trials.

Results: 192 patients were distributed by subgroups according to the medicine. Letrozole: OS 30.8 (95% confidence interval (CI) 20.6-41.4); TTF 11.2 (95%CI 8.7-13.7). Exemestane: OS 22.1 (95%CI 9.7-34.6); TTF 6.0 (95%CI 4.1-7.8). Fulvestrant: OS 21.6 (95%CI 16.5-26.7); TTF 5.6 (95%CI 4.5-6.6).

Conclusions: Estimated effectiveness (OS) of letrozole and fulvestrant was, respectively, 3.2-3.5 months lower than reported. The clinical meaning seems uncertain and may be explained a higher proportion of worse prognostic characteristics in patients treated in the real-world.

背景:在整合细胞周期依赖性激酶4/6抑制剂之前,芳香化酶抑制剂和氟维司群单药疗法是激素受体阳性(HR+)/人表皮生长因子受体2型阴性(HER2-)晚期乳腺癌的标准疗法。疗效数据对监管行动至关重要,但人们对芳香化酶抑制剂和氟维司群的实际使用情况知之甚少:利用癌症登记处的数据开展了一项回顾性队列研究,以确定葡萄牙主要肿瘤医院中接触过芳香化酶抑制剂或氟维司群的HR+/HER-晚期乳腺癌成年女性(2017年5月31日至2019年3月31日)。对病例进行更新,随访至死亡或截止日期(2021 年 3 月 31 日),并提取假匿名数据。主要结果为总生存期(OS),次要结果为治疗失败时间(TTF),采用生存分析进行估算,并与已发表的试验进行比较:192名患者根据药物进行了分组。来曲唑OS为30.8(95%置信区间(CI)为20.6-41.4);TTF为11.2(95%CI为8.7-13.7)。依西美坦OS:22.1(95%CI 9.7-34.6);TTF:6.0(95%CI 4.1-7.8)。氟维司群OS为21.6(95%CI为16.5-26.7);TTF为5.6(95%CI为4.5-6.6):结论:来曲唑和氟维司群的估计疗效(OS)分别比报告的低3.2-3.5个月。结论:来曲唑和氟维司群的估计有效期(OS)分别比报告的低3.2-3.5个月,其临床意义似乎并不确定,可能是因为在真实世界中接受治疗的患者中预后特征较差的比例较高。
{"title":"Real-world effectiveness of aromatase inhibitors and fulvestrant in HR+/HER2- advanced breast cancer: a snapshot of the last two years before conventional use of CDK 4/6 inhibitors in a Portuguese institution.","authors":"Maria Inês Teodoro, Alexandra Mayer, Ana da Costa Miranda, Hugo Nunes, Filipa Alves da Costa, António Lourenço","doi":"10.1080/20523211.2023.2296551","DOIUrl":"10.1080/20523211.2023.2296551","url":null,"abstract":"<p><strong>Background: </strong>Monotherapy with aromatase inhibitors and fulvestrant were the standard-of-care for hormone receptor-positive (HR+)/human epidermal growth factor receptor-type2 negative (HER2-) advanced breast cancer, before integration of cyclin-dependent kinase 4/6 inhibitors. Effectiveness data is essential for regulatory action, but little is known about real-world use of aromatase inhibitors and fulvestrant.</p><p><strong>Methods: </strong>A retrospective cohort study was conducted resorting to data from a cancer registry to identify adult women with HR+/HER- advanced breast cancer exposed to aromatase inhibitors or fulvestrant (31 May 2017-31 March 2019) at the main oncology hospital in Portugal. Cases were updated with follow-up until death or cut-off (31 March 2021) and pseudoanonymized data extracted. Primary outcome was overall survival (OS) and secondary time to treatment failure (TTF), estimated using survival analysis and compared with published trials.</p><p><strong>Results: </strong>192 patients were distributed by subgroups according to the medicine. Letrozole: OS 30.8 (95% confidence interval (CI) 20.6-41.4); TTF 11.2 (95%CI 8.7-13.7). Exemestane: OS 22.1 (95%CI 9.7-34.6); TTF 6.0 (95%CI 4.1-7.8). Fulvestrant: OS 21.6 (95%CI 16.5-26.7); TTF 5.6 (95%CI 4.5-6.6).</p><p><strong>Conclusions: </strong>Estimated effectiveness (OS) of letrozole and fulvestrant was, respectively, 3.2-3.5 months lower than reported. The clinical meaning seems uncertain and may be explained a higher proportion of worse prognostic characteristics in patients treated in the real-world.</p>","PeriodicalId":16740,"journal":{"name":"Journal of Pharmaceutical Policy and Practice","volume":"17 1","pages":"2296551"},"PeriodicalIF":4.2,"publicationDate":"2024-01-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10798277/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139512714","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Detecting manuscripts written by generative AI and AI-assisted technologies in the field of pharmacy practice. 在药学实践领域检测生成式人工智能和人工智能辅助技术撰写的稿件。
IF 4.2 Q1 HEALTH POLICY & SERVICES Pub Date : 2024-01-12 eCollection Date: 2024-01-01 DOI: 10.1080/20523211.2024.2303759
Ammar Abdulrahman Jairoun, Faris El-Dahiyat, Ghaleb A ElRefae, Sabaa Saleh Al-Hemyari, Moyad Shahwan, Samer H Zyoud, Khawla Abu Hammour, Zaheer-Ud-Din Babar

Generative AI can be a powerful research tool, but researchers must employ it ethically and transparently. This commentary addresses how the editors of pharmacy practice journals can identify manuscripts generated by generative AI and AI-assisted technologies. Editors and reviewers must stay well-informed about developments in AI technologies to effectively recognise AI-written papers. Editors should safeguard the reliability of journal publishing and sustain industry standards for pharmacy practice by implementing the crucial strategies outlined in this editorial. Although obstacles, including ignorance, time constraints, and protean AI strategies, might hinder detection efforts, several facilitators can help overcome those obstacles. Pharmacy practice journal editors and reviewers would benefit from educational programmes, collaborations with AI experts, and sophisticated plagiarism-detection techniques geared toward accurately identifying AI-generated text. Academics and practitioners can further uphold the integrity of published research through transparent reporting and ethical standards. Pharmacy practice journal staffs can sustain academic rigour and guarantee the validity of scholarly work by recognising and addressing the relevant barriers and utilising the proper enablers. Navigating the changing world of AI-generated content and preserving standards of excellence in pharmaceutical research and practice requires a proactive strategy of constant learning and community participation.

生成式人工智能可以成为一种强大的研究工具,但研究人员必须以道德和透明的方式使用它。本评论探讨了药学实践期刊的编辑如何识别由生成式人工智能和人工智能辅助技术生成的稿件。编辑和审稿人必须充分了解人工智能技术的发展,才能有效识别人工智能撰写的论文。编辑应通过实施本社论中概述的重要策略来保障期刊出版的可靠性,并维持药学实践的行业标准。尽管包括无知、时间限制和无穷无尽的人工智能战略在内的障碍可能会阻碍检测工作,但一些促进因素可以帮助克服这些障碍。药学实践期刊的编辑和审稿人将受益于教育计划、与人工智能专家的合作以及旨在准确识别人工智能生成文本的先进剽窃检测技术。学术界和从业人员可以通过透明的报告和道德标准进一步维护已发表研究的完整性。药学实践期刊的工作人员可以通过认识和解决相关障碍并利用适当的推动因素来维持学术严谨性并保证学术成果的有效性。要驾驭人工智能生成内容的不断变化的世界,并保持药学研究与实践的卓越标准,就必须采取不断学习和社区参与的积极策略。
{"title":"Detecting manuscripts written by generative AI and AI-assisted technologies in the field of pharmacy practice.","authors":"Ammar Abdulrahman Jairoun, Faris El-Dahiyat, Ghaleb A ElRefae, Sabaa Saleh Al-Hemyari, Moyad Shahwan, Samer H Zyoud, Khawla Abu Hammour, Zaheer-Ud-Din Babar","doi":"10.1080/20523211.2024.2303759","DOIUrl":"10.1080/20523211.2024.2303759","url":null,"abstract":"<p><p>Generative AI can be a powerful research tool, but researchers must employ it ethically and transparently. This commentary addresses how the editors of pharmacy practice journals can identify manuscripts generated by generative AI and AI-assisted technologies. Editors and reviewers must stay well-informed about developments in AI technologies to effectively recognise AI-written papers. Editors should safeguard the reliability of journal publishing and sustain industry standards for pharmacy practice by implementing the crucial strategies outlined in this editorial. Although obstacles, including ignorance, time constraints, and protean AI strategies, might hinder detection efforts, several facilitators can help overcome those obstacles. Pharmacy practice journal editors and reviewers would benefit from educational programmes, collaborations with AI experts, and sophisticated plagiarism-detection techniques geared toward accurately identifying AI-generated text. Academics and practitioners can further uphold the integrity of published research through transparent reporting and ethical standards. Pharmacy practice journal staffs can sustain academic rigour and guarantee the validity of scholarly work by recognising and addressing the relevant barriers and utilising the proper enablers. Navigating the changing world of AI-generated content and preserving standards of excellence in pharmaceutical research and practice requires a proactive strategy of constant learning and community participation.</p>","PeriodicalId":16740,"journal":{"name":"Journal of Pharmaceutical Policy and Practice","volume":"17 1","pages":"2303759"},"PeriodicalIF":4.2,"publicationDate":"2024-01-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10791078/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139478562","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Barriers to access of maternal health commodities among pregnant women in public health facilities in Ubungo Municipal Council, Tanzania 坦桑尼亚乌本古市议会公共医疗机构中孕妇获得孕产妇保健用品的障碍
IF 4.2 Q1 HEALTH POLICY & SERVICES Pub Date : 2024-01-09 DOI: 10.1080/20523211.2023.2300457
Doris Mollel, G. Kagashe, D. Asingizwe, Stany Banzimana, S. M. Maru, François Niragire
{"title":"Barriers to access of maternal health commodities among pregnant women in public health facilities in Ubungo Municipal Council, Tanzania","authors":"Doris Mollel, G. Kagashe, D. Asingizwe, Stany Banzimana, S. M. Maru, François Niragire","doi":"10.1080/20523211.2023.2300457","DOIUrl":"https://doi.org/10.1080/20523211.2023.2300457","url":null,"abstract":"","PeriodicalId":16740,"journal":{"name":"Journal of Pharmaceutical Policy and Practice","volume":"39 20","pages":""},"PeriodicalIF":4.2,"publicationDate":"2024-01-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139442776","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical pharmacists’ interventions for preventing adverse events in critically ill neonates in Qatar: an economic impact analysis 临床药剂师对卡塔尔危重新生儿不良事件的预防干预:经济影响分析
IF 4.2 Q1 HEALTH POLICY & SERVICES Pub Date : 2024-01-02 DOI: 10.1080/20523211.2023.2291508
Ola Yakti, D. Al-Badriyeh, M. Rijims, Mohammed Abdelaal, O. Alsoukhni, M. Al Hail, P. Abdulrouf, Wessam El-Kassem, Fouad F. Abounahia, R. Kaddoura, D. Abushanab
{"title":"Clinical pharmacists’ interventions for preventing adverse events in critically ill neonates in Qatar: an economic impact analysis","authors":"Ola Yakti, D. Al-Badriyeh, M. Rijims, Mohammed Abdelaal, O. Alsoukhni, M. Al Hail, P. Abdulrouf, Wessam El-Kassem, Fouad F. Abounahia, R. Kaddoura, D. Abushanab","doi":"10.1080/20523211.2023.2291508","DOIUrl":"https://doi.org/10.1080/20523211.2023.2291508","url":null,"abstract":"","PeriodicalId":16740,"journal":{"name":"Journal of Pharmaceutical Policy and Practice","volume":"69 9","pages":""},"PeriodicalIF":4.2,"publicationDate":"2024-01-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139452713","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessment of prices, availability and affordability of essential medicines in Juba County, South Sudan. 评估南苏丹朱巴县基本药物的价格、可获得性和可负担性。
IF 4.2 Q1 HEALTH POLICY & SERVICES Pub Date : 2023-12-30 DOI: 10.1186/s40545-023-00675-5
Justin Deng, Augustino Ting Mayai, Egide Kayitare, Theoneste Ntakirutimana, Omary Swallehe, Thomas Bizimana

Background: Access to safe, effective, affordable, and high-quality medications has been included in the Sustainable Development Goals (SDGs) of the United Nations as a crucial step towards attaining universal health coverage. Access to medicines is a fundamental human right. If medicines are accessible and affordable, they save lives by reducing mortality and morbidity associated with acute and chronic diseases. WHO recommends that all countries voluntarily reach the minimum target of 80% availability of medicines by 2025. The primary purpose of this research is to assess access to essential medicines in Juba County, South Sudan.

Methods: This study was undertaken using the standard World Health Organization/Health Action International Organization (WHO/HAI) approach for surveying the prices, availability, and affordability of medicines. A survey was conducted in six payams of Juba County, South Sudan, and 55 health facilities were assessed.

Results: Prices for generic medicines were better in faith-based health facilities with a median price ratio of 1.95. Private pharmacies and private clinics had MPRs of 4.64 and 4.32, respectively. Local prices were high compared to International referent prices. Availability of medicines was highest in the faith-based health facilities (65.5%) and slightly lower in private pharmacies (55.4%), private clinics (57.7%) and public (50.4%) sectors. Most of the surveyed medicines were unaffordable. The medicines needed to treat non-communicable diseases cost up to 33.7-day wages for one full course of treatment.

Conclusions: In South Sudan, medicines are poorly available in all sectors. Medicines are affordable in the public sector but Most medicines are unaffordable in private pharmacies, private clinics and faith-based health facilities. Poor medicines availability in the public sector contributes to the overall unaffordability of medicines in all the other sectors.

背景:获得安全、有效、负担得起的优质药品已被纳入联合国可持续发展目标(SDGs),作为实现全民医保的关键一步。获得药品是一项基本人权。如果能够获得负担得起的药品,就能降低与急性和慢性疾病相关的死亡率和发病率,从而挽救生命。世卫组织建议所有国家自愿实现到 2025 年药品供应率达到 80% 的最低目标。本研究的主要目的是评估南苏丹朱巴县的基本药物获取情况:本研究采用世界卫生组织/国际健康行动组织 (WHO/HAI) 的标准方法调查药品的价格、可用性和可负担性。在南苏丹朱巴县的六个乡进行了调查,并对 55 家医疗机构进行了评估:结果:信仰医疗机构的非专利药品价格较高,中位价格比为 1.95。私人药房和私人诊所的中位价格比分别为 4.64 和 4.32。与国际参考价格相比,当地价格偏高。宗教医疗机构的药品供应率最高(65.5%),私营药房(55.4%)、私营诊所(57.7%)和公共部门(50.4%)的药品供应率略低。大多数被调查的药品都买不起。治疗非传染性疾病所需的药品一个完整疗程的费用高达 33.7 天的工资:在南苏丹,所有部门的药品供应情况都很差。公共部门的药品价格低廉,但私人药房、私人诊所和宗教医疗机构的大多数药品价格昂贵。公共部门药品供应不足导致所有其他部门总体上买不起药品。
{"title":"Assessment of prices, availability and affordability of essential medicines in Juba County, South Sudan.","authors":"Justin Deng, Augustino Ting Mayai, Egide Kayitare, Theoneste Ntakirutimana, Omary Swallehe, Thomas Bizimana","doi":"10.1186/s40545-023-00675-5","DOIUrl":"10.1186/s40545-023-00675-5","url":null,"abstract":"<p><strong>Background: </strong>Access to safe, effective, affordable, and high-quality medications has been included in the Sustainable Development Goals (SDGs) of the United Nations as a crucial step towards attaining universal health coverage. Access to medicines is a fundamental human right. If medicines are accessible and affordable, they save lives by reducing mortality and morbidity associated with acute and chronic diseases. WHO recommends that all countries voluntarily reach the minimum target of 80% availability of medicines by 2025. The primary purpose of this research is to assess access to essential medicines in Juba County, South Sudan.</p><p><strong>Methods: </strong>This study was undertaken using the standard World Health Organization/Health Action International Organization (WHO/HAI) approach for surveying the prices, availability, and affordability of medicines. A survey was conducted in six payams of Juba County, South Sudan, and 55 health facilities were assessed.</p><p><strong>Results: </strong>Prices for generic medicines were better in faith-based health facilities with a median price ratio of 1.95. Private pharmacies and private clinics had MPRs of 4.64 and 4.32, respectively. Local prices were high compared to International referent prices. Availability of medicines was highest in the faith-based health facilities (65.5%) and slightly lower in private pharmacies (55.4%), private clinics (57.7%) and public (50.4%) sectors. Most of the surveyed medicines were unaffordable. The medicines needed to treat non-communicable diseases cost up to 33.7-day wages for one full course of treatment.</p><p><strong>Conclusions: </strong>In South Sudan, medicines are poorly available in all sectors. Medicines are affordable in the public sector but Most medicines are unaffordable in private pharmacies, private clinics and faith-based health facilities. Poor medicines availability in the public sector contributes to the overall unaffordability of medicines in all the other sectors.</p>","PeriodicalId":16740,"journal":{"name":"Journal of Pharmaceutical Policy and Practice","volume":"16 1","pages":"172"},"PeriodicalIF":4.2,"publicationDate":"2023-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10757353/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139074408","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pharmacist-led vaccination services in the Middle East. 中东以药剂师为主导的疫苗接种服务。
IF 4.2 Q1 HEALTH POLICY & SERVICES Pub Date : 2023-12-29 DOI: 10.1186/s40545-023-00664-8
Faten Naif Aldajani, Mohammed Aldosari

Successful Vaccine uptake relies heavily on the effectiveness of vaccination services. Expanding the scope of pharmacists' involvement in vaccination services can significantly improve vaccination coverage. The level of pharmacists' engagement in immunization services varies globally. The aim of this paper is to describe the current role of pharmacists in vaccination services in the Middle Eastern countries. The provision of vaccination services by pharmacists in the region has evolved notably in recent years. The extent of pharmacists' involvement in immunization services varies from one country to another in the region. They play a more active role in the delivery of vaccinations, not only facilitating but also administering vaccines. Future studies on pharmacist-led vaccination services in these countries are necessary to assess the value of the expanded practice of pharmacists in this field, especially due to the scarcity of evidence.

疫苗的成功接种在很大程度上取决于疫苗接种服务的有效性。扩大药剂师参与疫苗接种服务的范围可显著提高疫苗接种覆盖率。在全球范围内,药剂师参与免疫接种服务的程度各不相同。本文旨在介绍药剂师目前在中东国家疫苗接种服务中的作用。近年来,药剂师在该地区提供的疫苗接种服务有了显著发展。该地区各国药剂师参与免疫服务的程度各不相同。药剂师在提供疫苗接种服务中发挥着更加积极的作用,他们不仅提供便利,还负责疫苗接种。今后有必要对这些国家由药剂师主导的疫苗接种服务进行研究,以评估药剂师在这一领域扩大实践的价值,特别是由于证据不足。
{"title":"Pharmacist-led vaccination services in the Middle East.","authors":"Faten Naif Aldajani, Mohammed Aldosari","doi":"10.1186/s40545-023-00664-8","DOIUrl":"10.1186/s40545-023-00664-8","url":null,"abstract":"<p><p>Successful Vaccine uptake relies heavily on the effectiveness of vaccination services. Expanding the scope of pharmacists' involvement in vaccination services can significantly improve vaccination coverage. The level of pharmacists' engagement in immunization services varies globally. The aim of this paper is to describe the current role of pharmacists in vaccination services in the Middle Eastern countries. The provision of vaccination services by pharmacists in the region has evolved notably in recent years. The extent of pharmacists' involvement in immunization services varies from one country to another in the region. They play a more active role in the delivery of vaccinations, not only facilitating but also administering vaccines. Future studies on pharmacist-led vaccination services in these countries are necessary to assess the value of the expanded practice of pharmacists in this field, especially due to the scarcity of evidence.</p>","PeriodicalId":16740,"journal":{"name":"Journal of Pharmaceutical Policy and Practice","volume":"16 1","pages":"171"},"PeriodicalIF":4.2,"publicationDate":"2023-12-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10755951/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139058452","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development of the Pharmacist's Stress Scale for Home Care (PSS) and evaluation of its reliability and validity. 开发家庭护理药剂师压力量表 (PSS),并评估其可靠性和有效性。
IF 4.2 Q1 HEALTH POLICY & SERVICES Pub Date : 2023-12-28 DOI: 10.1186/s40545-023-00610-8
Ayana Kani, Manako Hanya, Hiroyuki Kamei, Kenta Murotani

Background: As the needs for home care increase, contact with patients and jobs out of the pharmacy such as the patients' homes have increased, and there is concern that the situation increases pharmacists' work-related stress. Stress deteriorates pharmacists' quality of life (QOL) and affects the quality of services they provide. In this study, we developed a scale for the measurement of stress of pharmacists engaged in home care and evaluated it in pharmacists in 3 prefectures of the Tokai district, Japan.

Methods: Based on the stress factors of pharmacists in home care extracted by previous studies, a 59-item questionnaire was developed. The questionnaires were sent to 1785 pharmacies engaged in home care in 3 prefectures of the Tokai district, and anonymous responses were obtained from 399 (valid response rate: 22.4%). The answers to each question were scored using 5-point scale (1: I feel no stress to 5: I always feel strong stress).

Results: As a result of factor analysis, the Pharmacist's Stress Scale for Home Care (PSS) was prepared with 51 items, i.e., 14 related to the first factor, "difficulty and feeling of incompetence in patient care", 9 related to the second factor, "relationship with superiors and work environment", 13 related to the third factor, "burdens related to work load and work contents", 10 related to the fourth factor, "communication with patients and families", and 5 related to the fifth factor, "communication with other professions". Cronbach's α coefficients for the entire scale and each factor were ≥ 0.833, and sufficient internal consistency was obtained.

Conclusions: The scale developed in this study is considered to be useful for the measurement of stress of pharmacists derived from interpersonal work and home care services. Leaving the job and burnout are expected to be prevented by perceiving the stress level of the pharmacists by themselves using this scale and coping with stress.

背景:随着家庭护理需求的增加,药剂师与病人的接触以及在病人家中等药房以外的工作也随之增加,人们担心这种情况会增加药剂师的工作压力。压力会降低药剂师的生活质量 (QOL),并影响他们提供服务的质量。在这项研究中,我们开发了一个用于测量从事家庭护理的药剂师压力的量表,并在日本东海地区 3 个县的药剂师中进行了评估:方法:根据以往研究中提取的药剂师在家庭护理中的压力因素,编制了一份 59 个项目的调查问卷。向东海县 3 个都道府县的 1785 家从事居家护理的药店发送了调查问卷,共收到 399 份匿名回复(有效回复率:22.4%)。每个问题的答案均采用 5 级评分法(1 分:我感觉不到压力,5 分:我总是感觉到强烈的压力):结果:经过因子分析,编制了药剂师家庭护理压力量表(PSS),共有 51 个条目,其中 14 个与第一因子 "患者护理中的困难和无能感 "有关,9 个与第二因子 "与上级的关系和工作环境 "有关,13 个与第三因子 "与工作量和工作内容有关的负担 "有关,10 个与第四因子 "与患者和家属的沟通 "有关,5 个与第五因子 "与其他行业的沟通 "有关。整个量表和每个因子的 Cronbach's α 系数均≥ 0.833,获得了充分的内部一致性:本研究编制的量表可用于测量药剂师在人际工作和家庭护理服务中产生的压力。通过使用该量表感知药剂师自身的压力水平并应对压力,有望预防离职和职业倦怠。
{"title":"Development of the Pharmacist's Stress Scale for Home Care (PSS) and evaluation of its reliability and validity.","authors":"Ayana Kani, Manako Hanya, Hiroyuki Kamei, Kenta Murotani","doi":"10.1186/s40545-023-00610-8","DOIUrl":"10.1186/s40545-023-00610-8","url":null,"abstract":"<p><strong>Background: </strong>As the needs for home care increase, contact with patients and jobs out of the pharmacy such as the patients' homes have increased, and there is concern that the situation increases pharmacists' work-related stress. Stress deteriorates pharmacists' quality of life (QOL) and affects the quality of services they provide. In this study, we developed a scale for the measurement of stress of pharmacists engaged in home care and evaluated it in pharmacists in 3 prefectures of the Tokai district, Japan.</p><p><strong>Methods: </strong>Based on the stress factors of pharmacists in home care extracted by previous studies, a 59-item questionnaire was developed. The questionnaires were sent to 1785 pharmacies engaged in home care in 3 prefectures of the Tokai district, and anonymous responses were obtained from 399 (valid response rate: 22.4%). The answers to each question were scored using 5-point scale (1: I feel no stress to 5: I always feel strong stress).</p><p><strong>Results: </strong>As a result of factor analysis, the Pharmacist's Stress Scale for Home Care (PSS) was prepared with 51 items, i.e., 14 related to the first factor, \"difficulty and feeling of incompetence in patient care\", 9 related to the second factor, \"relationship with superiors and work environment\", 13 related to the third factor, \"burdens related to work load and work contents\", 10 related to the fourth factor, \"communication with patients and families\", and 5 related to the fifth factor, \"communication with other professions\". Cronbach's α coefficients for the entire scale and each factor were ≥ 0.833, and sufficient internal consistency was obtained.</p><p><strong>Conclusions: </strong>The scale developed in this study is considered to be useful for the measurement of stress of pharmacists derived from interpersonal work and home care services. Leaving the job and burnout are expected to be prevented by perceiving the stress level of the pharmacists by themselves using this scale and coping with stress.</p>","PeriodicalId":16740,"journal":{"name":"Journal of Pharmaceutical Policy and Practice","volume":"16 1","pages":"170"},"PeriodicalIF":4.2,"publicationDate":"2023-12-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10753843/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139048928","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A cross-sectional assessment of the effects of select training modalities on vaccine cold chain management. 对选定培训模式对疫苗冷链管理的影响进行横向评估。
IF 4.2 Q1 HEALTH POLICY & SERVICES Pub Date : 2023-12-27 eCollection Date: 2024-01-01 DOI: 10.1080/20523211.2023.2292717
Aguma Daniel, Joseph Oloro, Innocent Hahirwa, Theogene Rizinde, Marie Francoise Mukanyangezi

Background: Vaccines offer arguably the most cost-effective public health intervention. Vaccine supply chain management which is a critical building block faces many Human resources challenges mainly due to the special attributes of vaccines.

Objective: This study attempted to measure the effect of training on vaccine cold chain handler knowledge and practices.

Methods: A cross-sectional research design, using predominantly quantitative data collection techniques, was used. Facilities that have offered vaccination services for more than a year and report through the HMIS system were eligible for selection. Observation checklists and structured questionnaires were used. SPSS was used to analyse data.

Results: Vaccine cold chain management among the study group had an average score of 65.33% range (31-85%). The average knowledge score among the study respondents was 62.42% with a range (45-95%). The knowledge of respondents generally increases with an additional increase in the number of training modalities.

Conclusions: The status of VCCM is at about 65.33% below the target of 80% set by the EVM. The trainings have an effect on both knowledge of handlers and their practice especially when deployed in a multi-pronged design and thus these trainings need to be aligned to achieve synergy.

Abbreviations: CCE, Cold Chain Equipment; DHIS2, District Health Information Systems 2; DHO, District Health Officer; DPT, Diphtheria, Pertussis, Tetanus; DVS, District Vaccine Stores; EPI, Expanded Program for Immunisation; EVM, Effective Vaccine Management; FEFO, First Expiry First Out; GAVI, Global Alliance for Vaccines and Immunisation; HMIS, Health Information Management Systems; IRC, International Rescue Committee; KII, Key Informant Interview; LIAT, logistics indicator assessment tool; PATH, Program for Appropriate Technology in Health; PHC, Primary Health Care; QPPU, Quantification and Planning and Procurement Unit; SOPs, Standard Operating Procedures; SPSS, Statistical Package for Social Sciences; UNEPI, Uganda National Expanded Program for Immunisation; UNICEF, United Nations Children's Fund; VPD, Vaccine Preventable Diseases; VVM, Vaccine Vial Monitors; WHO, World Health Organisation.

背景:疫苗可以说是最具成本效益的公共卫生干预措施。疫苗供应链管理是一个关键的组成部分,主要由于疫苗的特殊属性,它面临着许多人力资源方面的挑战:本研究试图衡量培训对疫苗冷链处理人员知识和实践的影响:方法:采用横断面研究设计,主要使用定量数据收集技术。提供疫苗接种服务一年以上并通过 HMIS 系统进行报告的机构均可入选。使用了观察核对表和结构化问卷。使用 SPSS 对数据进行分析:研究组疫苗冷链管理的平均得分率为 65.33%,范围在 31%-85%之间。研究对象的平均知识得分率为 62.42%,得分范围为(45-95%)。随着培训方式的增加,受访者的知识水平普遍提高:VCCM 的知晓率约为 65.33%,低于 EVM 设定的 80%的目标。培训对处理人员的知识和实践都有影响,特别是在多管齐下的设计中,因此需要对这些培训进行调整,以实现协同增效:缩写:CCE,冷链设备;DHIS2,地区卫生信息系统 2;DHO,地区卫生官员;DPT,白喉、百日咳、破伤风;DVS,地区疫苗仓库;EPI,扩大免疫计划;EVM,有效疫苗管理;FEFO,先到期先用完;GAVI,全球疫苗和免疫联盟;HMIS,卫生信息管理系统;IRC,国际救援委员会;KII,关键信息提供者访谈;LIAT,物流指标评估工具;PATH,适当卫生技术计划;PHC,初级卫生保健;QPPU,量化和规划与采购股;SOPs,标准操作程序;SPSS,社会科学统计软件包;UNEPI,乌干达国家扩大免疫计划;UNICEF,联合国儿童基金会;VPD,疫苗可预防疾病;VVM,疫苗瓶监测器;WHO,世界卫生组织。
{"title":"A cross-sectional assessment of the effects of select training modalities on vaccine cold chain management.","authors":"Aguma Daniel, Joseph Oloro, Innocent Hahirwa, Theogene Rizinde, Marie Francoise Mukanyangezi","doi":"10.1080/20523211.2023.2292717","DOIUrl":"10.1080/20523211.2023.2292717","url":null,"abstract":"<p><strong>Background: </strong>Vaccines offer arguably the most cost-effective public health intervention. Vaccine supply chain management which is a critical building block faces many Human resources challenges mainly due to the special attributes of vaccines.</p><p><strong>Objective: </strong>This study attempted to measure the effect of training on vaccine cold chain handler knowledge and practices.</p><p><strong>Methods: </strong>A cross-sectional research design, using predominantly quantitative data collection techniques, was used. Facilities that have offered vaccination services for more than a year and report through the HMIS system were eligible for selection. Observation checklists and structured questionnaires were used. SPSS was used to analyse data.</p><p><strong>Results: </strong>Vaccine cold chain management among the study group had an average score of 65.33% range (31-85%). The average knowledge score among the study respondents was 62.42% with a range (45-95%). The knowledge of respondents generally increases with an additional increase in the number of training modalities.</p><p><strong>Conclusions: </strong>The status of VCCM is at about 65.33% below the target of 80% set by the EVM. The trainings have an effect on both knowledge of handlers and their practice especially when deployed in a multi-pronged design and thus these trainings need to be aligned to achieve synergy.</p><p><strong>Abbreviations: </strong>CCE, Cold Chain Equipment; DHIS2, District Health Information Systems 2; DHO, District Health Officer; DPT, Diphtheria, Pertussis, Tetanus; DVS, District Vaccine Stores; EPI, Expanded Program for Immunisation; EVM, Effective Vaccine Management; FEFO, First Expiry First Out; GAVI, Global Alliance for Vaccines and Immunisation; HMIS, Health Information Management Systems; IRC, International Rescue Committee; KII, Key Informant Interview; LIAT, logistics indicator assessment tool; PATH, Program for Appropriate Technology in Health; PHC, Primary Health Care; QPPU, Quantification and Planning and Procurement Unit; SOPs, Standard Operating Procedures; SPSS, Statistical Package for Social Sciences; UNEPI, Uganda National Expanded Program for Immunisation; UNICEF, United Nations Children's Fund; VPD, Vaccine Preventable Diseases; VVM, Vaccine Vial Monitors; WHO, World Health Organisation.</p>","PeriodicalId":16740,"journal":{"name":"Journal of Pharmaceutical Policy and Practice","volume":"17 1","pages":"232-248"},"PeriodicalIF":4.2,"publicationDate":"2023-12-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10793629/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139485723","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Providing anti-retroviral treatment did not achieve the ambition of 'Joint united nations program on HIV/AIDS (UNAIDS) among HIV positive patient in Ethiopia': a systematic review and meta-analysis. 提供抗逆转录病毒治疗并未实现 "联合国艾滋病规划署(UNAIDS)在埃塞俄比亚艾滋病毒阳性患者中的联合计划 "的目标:系统回顾和荟萃分析。
IF 4.2 Q1 HEALTH POLICY & SERVICES Pub Date : 2023-12-27 eCollection Date: 2024-01-01 DOI: 10.1080/20523211.2023.2290672
Tamirat Melis, Tadesse Sahle, Kassahun Haile, Abebe Timerga, Amare Zewdie, Yohannes Wegu, Kebebush Zepire, Jemal Bedewi

Introduction: Antiretroviral Treatment (ART) has great importance in reducing viral load. Though a global effort was made to suppress viral load, the level of viral load suppression among ART patients is still high in Ethiopia.

Objective: This study aims to assess the magnitude and contributing factors for viral load suppression among patients attending ART clinics in Ethiopia.

Methods: The articles were searched using different databases using the guideline of reporting systematic review and meta-analysis (PRISMA). A random effect model was used to ascertain the pooled prevalence of viral load suppression in Ethiopia using STATA 14 software.

Results: The pooled prevalence of suppressed viral load was 75.25% (95% CI: 68.61-81.89). Having good adherence (OR: 2.71, 95% CI 2.27, 3.15), baseline CD4 count (OR: 1.74, 95% CI 1.53, 1.96), and being female (OR: 1.41, 95% CI 1.04, 1.79) were determinants of pooled estimates of suppressed viral load.

Conclusion: The pooled prevalence of suppressed viral load was 75% which is lower than the targeted level by the sustainable development goal (SDG) 2020, which was 90%. Therefore, the stakeholders should be focused on the existing strategies to decrease viral load among ART patients. They should work to adhere to patients for ART treatment.

简介抗逆转录病毒治疗(ART)对降低病毒载量具有重要意义。尽管全球都在努力抑制病毒载量,但在埃塞俄比亚,抗逆转录病毒疗法患者的病毒载量抑制水平仍然很高:本研究旨在评估埃塞俄比亚抗逆转录病毒疗法门诊患者病毒载量抑制的程度和诱因:采用系统综述和荟萃分析报告指南(PRISMA)在不同数据库中检索文章。使用 STATA 14 软件,采用随机效应模型确定埃塞俄比亚病毒载量抑制的总体流行率:病毒载量抑制的总体流行率为 75.25%(95% CI:68.61-81.89)。良好的依从性(OR:2.71,95% CI:2.27,3.15)、基线 CD4 细胞数(OR:1.74,95% CI:1.53,1.96)和女性(OR:1.41,95% CI:1.04,1.79)是病毒载量被抑制的集合估计值的决定因素:病毒载量得到抑制的总体流行率为 75%,低于可持续发展目标(SDG)2020 的目标水平(90%)。因此,利益相关方应关注现有的降低抗逆转录病毒疗法患者病毒载量的策略。他们应努力使患者坚持接受抗逆转录病毒疗法治疗。
{"title":"Providing anti-retroviral treatment did not achieve the ambition of 'Joint united nations program on HIV/AIDS (UNAIDS) among HIV positive patient in Ethiopia': a systematic review and meta-analysis.","authors":"Tamirat Melis, Tadesse Sahle, Kassahun Haile, Abebe Timerga, Amare Zewdie, Yohannes Wegu, Kebebush Zepire, Jemal Bedewi","doi":"10.1080/20523211.2023.2290672","DOIUrl":"10.1080/20523211.2023.2290672","url":null,"abstract":"<p><strong>Introduction: </strong>Antiretroviral Treatment (ART) has great importance in reducing viral load. Though a global effort was made to suppress viral load, the level of viral load suppression among ART patients is still high in Ethiopia.</p><p><strong>Objective: </strong>This study aims to assess the magnitude and contributing factors for viral load suppression among patients attending ART clinics in Ethiopia.</p><p><strong>Methods: </strong>The articles were searched using different databases using the guideline of reporting systematic review and meta-analysis (PRISMA). A random effect model was used to ascertain the pooled prevalence of viral load suppression in Ethiopia using STATA 14 software.</p><p><strong>Results: </strong>The pooled prevalence of suppressed viral load was 75.25% (95% CI: 68.61-81.89). Having good adherence (OR: 2.71, 95% CI 2.27, 3.15), baseline CD4 count (OR: 1.74, 95% CI 1.53, 1.96), and being female (OR: 1.41, 95% CI 1.04, 1.79) were determinants of pooled estimates of suppressed viral load.</p><p><strong>Conclusion: </strong>The pooled prevalence of suppressed viral load was 75% which is lower than the targeted level by the sustainable development goal (SDG) 2020, which was 90%. Therefore, the stakeholders should be focused on the existing strategies to decrease viral load among ART patients. They should work to adhere to patients for ART treatment.</p>","PeriodicalId":16740,"journal":{"name":"Journal of Pharmaceutical Policy and Practice","volume":"17 1","pages":"2290672"},"PeriodicalIF":4.2,"publicationDate":"2023-12-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10793635/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139485737","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Psychological dynamics of pandemic resilience: a tale of two cultures. 大流行病复原力的心理动态:两种文化的故事。
IF 4.2 Q1 HEALTH POLICY & SERVICES Pub Date : 2023-12-27 eCollection Date: 2024-01-01 DOI: 10.1080/20523211.2023.2291509
Shazia Rehman, Erum Rehman, Akhlaq Awan

The present work endeavours to explore the experiences of university-level students from Pakistan and Nepal after the COVID-19 outbreak. A comprehensive electronic survey was carried out utilising a meticulous cluster sampling technique encompassing two distinct populations, i.e. Pakistan and Nepal, during the period extending from September 2022 to January 2023. A total of 2496 participants completed the questionnaire (Pakistani population: 55.45% and Nepalese population: 44.55%). We utilised the Mental Health Continuum-Short Form (MHC-SF), Pittsburgh Sleep Quality Index (PSQI), feeling of loneliness (UCLA), interdependent happy scale (IHS), and fear of COVID-19 scale (FCV-19S). Notably, a significant intercultural disparity was observed, particularly concerning the level of COVID-19 fear which was higher among the Nepalese population. However, this particular variable did not demonstrate any significant associations with other variables, except for the social dimension of MHC-SF. There was a negative correlation observed between this variable and IHS within the Pakistani population. Irrespective of the varying degrees of apprehension towards COVID-19 within the two distinct cultural contexts, there exists a significant positive correlation between the assessed psychological assets and individual well-being, as well as the resumption of regular activities after the outbreak.

本研究旨在探讨 COVID-19 爆发后巴基斯坦和尼泊尔大学生的经历。在 2022 年 9 月至 2023 年 1 月期间,采用细致的分组抽样技术,对巴基斯坦和尼泊尔两个不同的人群进行了全面的电子调查。共有 2496 名参与者填写了调查问卷(巴基斯坦人占 55.45%,尼泊尔人占 44.55%)。我们采用了心理健康连续简表(MHC-SF)、匹兹堡睡眠质量指数(PSQI)、孤独感(UCLA)、快乐相互依存量表(IHS)和 COVID-19 恐惧量表(FCV-19S)。值得注意的是,不同文化间存在明显差异,尤其是尼泊尔人对 COVID-19 的恐惧程度更高。然而,除 MHC-SF 的社会维度外,该变量与其他变量并无明显关联。在巴基斯坦人口中,该变量与 IHS 之间呈负相关。尽管在两种不同的文化背景下,人们对 COVID-19 的忧虑程度各不相同,但所评估的心理资产与个人幸福感以及在疫情爆发后恢复正常活动之间存在着显著的正相关关系。
{"title":"Psychological dynamics of pandemic resilience: a tale of two cultures.","authors":"Shazia Rehman, Erum Rehman, Akhlaq Awan","doi":"10.1080/20523211.2023.2291509","DOIUrl":"10.1080/20523211.2023.2291509","url":null,"abstract":"<p><p>The present work endeavours to explore the experiences of university-level students from Pakistan and Nepal after the COVID-19 outbreak. A comprehensive electronic survey was carried out utilising a meticulous cluster sampling technique encompassing two distinct populations, i.e. Pakistan and Nepal, during the period extending from September 2022 to January 2023. A total of 2496 participants completed the questionnaire (Pakistani population: 55.45% and Nepalese population: 44.55%). We utilised the Mental Health Continuum-Short Form (MHC-SF), Pittsburgh Sleep Quality Index (PSQI), feeling of loneliness (UCLA), interdependent happy scale (IHS), and fear of COVID-19 scale (FCV-19S). Notably, a significant intercultural disparity was observed, particularly concerning the level of COVID-19 fear which was higher among the Nepalese population. However, this particular variable did not demonstrate any significant associations with other variables, except for the social dimension of MHC-SF. There was a negative correlation observed between this variable and IHS within the Pakistani population. Irrespective of the varying degrees of apprehension towards COVID-19 within the two distinct cultural contexts, there exists a significant positive correlation between the assessed psychological assets and individual well-being, as well as the resumption of regular activities after the outbreak.</p>","PeriodicalId":16740,"journal":{"name":"Journal of Pharmaceutical Policy and Practice","volume":"17 1","pages":"2291509"},"PeriodicalIF":4.2,"publicationDate":"2023-12-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10793633/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139486929","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Pharmaceutical Policy and Practice
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1